News and Events
2020.02.10 Leading Life Science Clusters of Kawasaki and Munich extend their cooperation agreement: Ceremonial signing of Memorandum of Understanding
2019.11.11 JSR to establish the new JSR Bioscience and Informatics R & D Center in Tonomachi, Kawasaki City
2019.09.20 PeptiDream and JSR Initiate a Joint Development Program to Identify Peptides Applicable to Affinity Chromatography
2019.06.10 【PeptiDream Inc.】「On line article about Patrick Reid, PeptiDream representative director and president, published in Forbes.」
2019.06.04 【NanoCarrier Co.,Ltd.】「Press release by VBL Therapeutics on “VBL Final Phase 1/2 Study Results Presented at ASCO Demonstrate VB-111 Dose Dependent Increase in Overall Survival and 58% CA-125 Response Rate in Platinum-Resistant Ovarian Cancer”」
2019.06.04 【NanoCarrier Co.,Ltd.】「Press release by VBL Therapeutics on “Radiographic Analysis of VB-111 Phase 2 and 3 Clinical Trials in Recurrent Glioblastoma Shows Survival Benefit Associated with Objective Responses and Distinct Signature of VB-111 Activity”」
2019.03.29 【Braizon Therapeutics,Inc.】「Commencement of U.S.A. Operations at LabCentral in Boston, MA.」
2019.02.18 Keio University, Keio University Hospital
2018.03.06 Keio University sets up consultation desk for entrepreneurs at Tonomachi Wellbeing Research Campus
2017.12.19 CYBERDYNE obtained marketing clearance from U.S. FDA for Medical HAL as a medical device.
2017.08.04 Medtronic Innovation Center Japan to be opened at Kawasaki KINGSKYFRONT on 1 September 2017
2017.08.03 Tokyo Institute of Technology and Kawasaki City are Combining Forces in R&D on Computational Drug Discovery for Middle Molecules at Kawasaki KING SKYFRONT
2016.12.15 3rd COINS International Symposium "Towards Smart Health Society - Challenge of Kawasaki based Medical Innovation -"
2016.09.30 Commencement of investigator-initiated clinical trial of stroke patients using HAL® for Medical Use (Single-Leg Model) ~Step towards the medical device approval and expansion of Cybernic treatment~
2016.06.23 Under the supervision of medical professionals, the manual for proper usage of HAL® for Medical Use (Lower Limb Type) has now been published ~ Commencement of the world’s first insured robotic treatment covered under general public health insurance ~
2016.06.20 Ceremony to commemorate the completion of the Create Medic Research and Development Center
2015.12.24 NanoCarrier Co., Ltd. announces start of phase one clinical trials in Taiwan of drug delivery product for treatment of head and neck cancer.
2015.12.03 Application for national health insurance coverage for HAL for Medical Use (Lower Limb Type) submitted to the Ministry of Health, Labour and Welfare
2015.11.25 HAL for Medical Use (Lower Limb Type) received approval to be manufactured and sold as a medical device by the Ministry of Health, Labour and Welfare
2015.10.13 KINGSKYFRONT concept images updated
2015.09.29 Fujifilm establishes “Cellular Dynamics International Japan” to launch iPSC business for drug discovery support in Tonomachi (Kawasaki, Japan)
2015.09.29 Next Generation Robots Introduced to Haneda Airport Domestic Passenger Terminal! ~HAL® for Labor Support (Lumbar type), Transport Robot, and Cleaning Robot Commence Operations~
2015.06.10 Kazunori Kataoka and colleagues publish paper on ‘chemical surgery’ for cancer treatment.
2014.11.15 CYBERDYNE Inc. submitted final application for market clearance from the U.S. Food and Drug Administration (“FDA”) ~ the first DeNovo submission by a Japanese company for a “novel” medical device
2014.11.12 HAL received the world-first certificates of an international safety standard as wearable robots for workers and caregivers
2014.09.30 CYBERDYNE Inc. launched HAL® for Task Support to enter fields of heavy work assistance devices
2014.09.22 Article regarding efficacy of HAL For Medical Use was published in US medical magazine “Neurology”
2014.07.01 Johnson & Johnson Opens Tokyo Science Center